Clinical Trial Update: Efficacy and Safety of DEB-TACE Combined With HAIC Versus HAIC Alone in Patients With Unresectable CRLM

View source ↗

Summary

A planned clinical trial comparing DEB-TACE combined with hepatic artery infusion chemotherapy (HAIC) versus HAIC alone for unresectable colorectal liver metast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Colorectal Liver Metastases

Drugs mentioned

• DEB-TACE
• HAIC (hepatic artery infusion chemotherapy)

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Colorectal Cancer Metastatic | Status: NOT_YET_RECRUITING